Skip to main content
    S

    Septerna, Inc. Common Stock (SEPN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $41.67
    -0.93 (-2.18%)

    Market Cap: $2.03B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Septerna, Inc. Common Stock (SEPN) Financials: Revenue, Profit and Cash Flow

    Updated Nov 9, 2026. Financial statements from company filings, amounts in US dollars.

    Septerna, Inc. Common Stock reported revenue of $45.95M for the fiscal year ended Dec 31, 2025, up 4174.5% from the year before. That year, net income was -$48.88M with a net margin of -106.4%, operating cash flow was $110.19M and free cash flow was $109.67M. The quarter ended Sep 30, 2026 had revenue of $18.88M and net income of -$26.59M.

    Revenue and Margins

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$45.95M+4174.5%100.0%-148.6%-106.4%
    Dec 2024$1.07M+611.9%100.0%-7518.4%-6678.9%
    Dec 2023$151.00KN/A100.0%1374.2%2768.2%
    Dec 2022$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2022 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Revenue$45.95M$1.07M$151.00K$0
    Gross profit$45.95M$1.07M$151.00KN/A
    Research and development$97.58M$65.34M$35.98M$22.04M
    Operating income-$68.30M-$80.82M$2.08M-$27.97M
    Net income-$48.88M-$71.80M$4.18M-$27.68M
    EBITDAN/AN/A$2.92M-$27.39M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$18.88M$26.75M$26.52M$24.12M$21.50M$119.00K$219.00K$212.00K$176.00K$370.00K$317.00K$118.00K
    Gross profit$18.88M$26.75M$26.52M$24.12M$21.50M$119.00K$219.00K$212.00K$176.00K$370.00K$317.00K$118.00K
    Operating income-$27.23M-$16.84M-$13.30M-$16.02M$2.61M-$28.98M-$25.91M-$24.72M-$22.55M-$18.07M-$15.49M$34.32M
    Net income-$26.59M-$13.03M-$8.64M-$10.74M$8.17M-$24.84M-$21.48M-$20.67M-$20.52M-$16.44M-$14.17M$34.89M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $2.21M by $118.51M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Total assets$596.19M$456.55M$130.87M$36.12M
    Current assets$410.96M$356.82M$112.68M$31.89M
    Cash and equivalents$120.72M$238.20M$88.48M$30.61M
    Total liabilities$214.26M$36.51M$20.03M$80.32M
    Short-term debt$2.21M$1.85MN/A$710.00K
    Shareholder equity$381.93M$420.05M-$38.37M-$44.20M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$619.40M$566.74M$569.69M$596.19M$606.65M$415.23M$434.02M$456.55M$174.28M$176.63MN/A$130.87M
    Total liabilities$191.47M$180.02M$191.23M$214.26M$217.92M$37.67M$33.75M$36.51M$37.53M$244.40MN/A$169.24M
    Cash and equivalents$167.12M$84.66M$71.61M$120.72M$319.99M$189.31M$210.04M$238.20M$88.24M$131.17MN/A$88.48M
    Shareholder equity$427.93M$386.72M$378.46M$381.93M$388.73M$377.56M$400.27M$420.05M-$87.41M-$67.76MN/A-$38.37M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 99.5% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Operating cash flow$110.19M-$67.47M-$38.72M-$23.30M
    Capital expenditures$518.00K$2.10M$2.88M$1.29M
    Free cash flow$109.67M-$69.57M-$41.60M-$24.59M
    Share repurchasesN/A$1.00K$1.00KN/A
    Investing cash flow-$229.35M-$160.60M$22.12M-$1.29M
    Financing cash flow$1.69M$377.78M$74.52M$30.05M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$13.77M-$22.18M-$25.63M-$14.99M$168.81M-$20.29M-$23.34M-$20.96M-$16.81M-$12.99M-$16.71M-$8.80M
    Capital expenditures$127.00KN/A$832.00K$65.00K$13.00K$58.00K$382.00K$612.00K$578.00K$149.00K$764.00K$1.24M
    Free cash flow-$13.89MN/A-$26.46M-$15.05M$168.79M-$20.34M-$23.73M-$21.57M-$17.39M-$13.14M-$17.48M-$10.04M
    Last 12 quarters

    Frequently Asked Questions About SEPN

    What is Septerna, Inc. Common Stock's annual revenue?

    Septerna, Inc. Common Stock reported revenue of $45.95M for the fiscal year ended Dec 31, 2025.

    How fast is Septerna, Inc. Common Stock's revenue growing?

    Revenue was up 4174.5% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is Septerna, Inc. Common Stock profitable?

    No. Septerna, Inc. Common Stock reported net income of -$48.88M for the fiscal year ended Dec 31, 2025, with a net margin of -106.4%.

    How much free cash flow does SEPN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $110.19M minus capital expenditures of $518.00K produced free cash flow of $109.67M.

    How much debt does Septerna, Inc. Common Stock have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $2.21M and cash and equivalents of $120.72M.